Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

This study has been completed.

Sponsor:

Collaborator:

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00053027

First received: January 27, 2003

Last updated: December 2, 2009

Last verified: September 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)